Literature DB >> 18344994

Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses.

Sofia Papadia1, Francesc X Soriano, Frédéric Léveillé, Marc-Andre Martel, Kelly A Dakin, Henrik H Hansen, Angela Kaindl, Marco Sifringer, Jill Fowler, Vanya Stefovska, Grahame McKenzie, Marie Craigon, Roderick Corriveau, Peter Ghazal, Karen Horsburgh, Bruce A Yankner, David J A Wyllie, Chrysanthy Ikonomidou, Giles E Hardingham.   

Abstract

Intrinsic antioxidant defenses are important for neuronal longevity. We found that in rat neurons, synaptic activity, acting via NMDA receptor (NMDAR) signaling, boosted antioxidant defenses by making changes to the thioredoxin-peroxiredoxin (Prx) system. Synaptic activity enhanced thioredoxin activity, facilitated the reduction of overoxidized Prxs and promoted resistance to oxidative stress. Resistance was mediated by coordinated transcriptional changes; synaptic NMDAR activity inactivated a previously unknown Forkhead box O target gene, the thioredoxin inhibitor Txnip. Conversely, NMDAR blockade upregulated Txnip in vivo and in vitro, where it bound thioredoxin and promoted vulnerability to oxidative damage. Synaptic activity also upregulated the Prx reactivating genes Sesn2 (sestrin 2) and Srxn1 (sulfiredoxin), via C/EBPbeta and AP-1, respectively. Mimicking these expression changes was sufficient to strengthen antioxidant defenses. Trans-synaptic stimulation of synaptic NMDARs was crucial for boosting antioxidant defenses; chronic bath activation of all (synaptic and extrasynaptic) NMDARs induced no antioxidative effects. Thus, synaptic NMDAR activity may influence the progression of pathological processes associated with oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344994      PMCID: PMC2556874          DOI: 10.1038/nn2071

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  50 in total

Review 1.  Neural activity and survival in the developing nervous system.

Authors:  S Mennerick; C F Zorumski
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

2.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

3.  Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death.

Authors:  Sheng-Jia Zhang; Marvin N Steijaert; David Lau; Günther Schütz; Celine Delucinge-Vivier; Patrick Descombes; Hilmar Bading
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

4.  Temporary changes of the AP-1 transcription factor binding activity in the gerbil hippocampus after transient global ischemia, and ischemic tolerance induction.

Authors:  K Kapinya; R Penzel; C Sommer; M Kiessling
Journal:  Brain Res       Date:  2000-07-28       Impact factor: 3.252

5.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways.

Authors:  G E Hardingham; Y Fukunaga; H Bading
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

6.  Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins.

Authors:  Hyun Ae Woo; Woojin Jeong; Tong-Shin Chang; Kwang Joo Park; Sung Jun Park; Jeong Soo Yang; Sue Goo Rhee
Journal:  J Biol Chem       Date:  2004-12-08       Impact factor: 5.157

7.  Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.

Authors:  Alexandra H Minn; Christian Hafele; Anath Shalev
Journal:  Endocrinology       Date:  2005-02-10       Impact factor: 4.736

8.  Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD.

Authors:  Andrei V Budanov; Anna A Sablina; Elena Feinstein; Eugene V Koonin; Peter M Chumakov
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

Review 9.  The dichotomy of NMDA receptor signaling.

Authors:  Sofia Papadia; Giles E Hardingham
Journal:  Neuroscientist       Date:  2007-12       Impact factor: 7.519

10.  Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains.

Authors:  M F Sánchez-Font; J Sebastià; C Sanfeliu; R Cristòfol; G Marfany; R Gonzàlez-Duarte
Journal:  Cell Mol Life Sci       Date:  2003-07       Impact factor: 9.261

View more
  245 in total

1.  Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons.

Authors:  Nadezhda V Povysheva; Jon W Johnson
Journal:  J Neurophysiol       Date:  2012-01-11       Impact factor: 2.714

Review 2.  Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms.

Authors:  Michael A Collins; Edward J Neafsey; Kewei Wang; Nicholas J Achille; Robert M Mitchell; Sreevidya Sivaswamy
Journal:  Mol Neurobiol       Date:  2010-04-28       Impact factor: 5.590

3.  Human embryonic stem cell-derived neurons as a tool for studying neuroprotection and neurodegeneration.

Authors:  Giles E Hardingham; Rickie Patani; Paul Baxter; David J Wyllie; Siddharthan Chandran
Journal:  Mol Neurobiol       Date:  2010-04-30       Impact factor: 5.590

4.  Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection.

Authors:  David T Stark; Nicolas G Bazan
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

5.  CRMP5-associated GTPase (CRAG) protein protects neuronal cells against cytotoxicity of expanded polyglutamine protein partially via c-Fos-dependent activator protein-1 activation.

Authors:  Shun Nagashima; Toshifumi Fukuda; Yuka Kubota; Ayumu Sugiura; Mitsuyoshi Nakao; Ryoko Inatome; Shigeru Yanagi
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

6.  Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses.

Authors:  Peng Xia; Huei-sheng Vincent Chen; Dongxian Zhang; Stuart A Lipton
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

Review 7.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

8.  Developmental and activity-dependent expression of LanCL1 confers antioxidant activity required for neuronal survival.

Authors:  Chao Huang; Mina Chen; Dejiang Pang; Dandan Bi; Yi Zou; Xiaoqiang Xia; Weiwei Yang; Liping Luo; Rongkang Deng; Honglin Tan; Liang Zhou; Shouyang Yu; Liheng Guo; XiaoXia Du; Yiyuan Cui; Jiahua Hu; Qing Mao; Paul F Worley; Bo Xiao
Journal:  Dev Cell       Date:  2014-08-25       Impact factor: 12.270

9.  Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.

Authors:  You Hyun Noh; Jin Young Baek; Woojin Jeong; Sue Goo Rhee; Tong-Shin Chang
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

10.  Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.

Authors:  Yubin Wang; Victor Briz; Athar Chishti; Xiaoning Bi; Michel Baudry
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.